125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: Effect of MPTP and dopaminomimetic treatments

Experimental Neurology

Volumn 163, Issue 1, 2000, Pages 191-199

  Calon, Frédéric ^a,b   Morissette, Marc ^a,b   Goulet, Martin ^a,b   Grondin, Richard ^a,b   Blanchet, Pierre J ^a,b   Bédard, Paul J ^a,b   Di Paolo, Thérèse ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Autoradiography; Basal ganglia; Dopamine agonist; Dyskinesia; GABA; Parkinson

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ANTIPARKINSON AGENT; BENZAZEPINE DERIVATIVE; BENZOIC ACID DERIVATIVE; CABERGOLINE; CGP 64213; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOLINE DERIVATIVE; ORGANOPHOSPHORUS COMPOUND; RADIOACTIVE IODINE; SK&F 82958; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE;

ANIMAL; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BINDING SITE; BRAIN; CHEMICALLY INDUCED DISORDER; CORPUS STRIATUM; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG EFFECT; DYSKINESIA; FEMALE; MACACA; METABOLISM; PARKINSON DISEASE; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA; THALAMUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; GLOBUS PALLIDUS; HABENULA; NEUROTRANSMISSION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; ANTIPARKINSON AGENTS; AUTORADIOGRAPHY; BASAL GANGLIA; BENZAZEPINES; BENZOATES; BINDING SITES; BRAIN; CORPUS STRIATUM; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; ERGOLINES; FEMALE; GABA ANTAGONISTS; INJECTIONS, SUBCUTANEOUS; IODINE RADIOISOTOPES; MACACA FASCICULARIS; ORGANOPHOSPHORUS COMPOUNDS; PARKINSON DISEASE, SECONDARY; RECEPTORS, GABA-B; SUBSTANTIA NIGRA; THALAMUS;

EID: 0033624807     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7366     Document Type: Article

References (58)

1. R.L. Albin R.H. Price S.Y. Sakurai J.B. Penney A.B. Young Excitatory and inhibitory amino acid binding sites in human dentate nucleus Brain Res. 560 1991 350 353
2. R.L. Albin A.B. Young J.B. Penney The functional anatomy of basal ganglia disorders Trends Neurosci. 12 1989 366 375
3. B. Bettler K. Kaupmann N. Bowery GABAB receptors: Drugs meet clones Curr. Opin. Neurobiol. 8 1998 345 350
4. S. Bischoff S. Leonhard N. Reymann V. Schuler R. Shigemoto K. Kaupmann B. Bettler Spatial distribution of GABA(B)R1 receptor mRNA and binding sites in the rat brain J. Comp. Neurol. 412 1999 1 16
5. H. Bittiger W. Froestl S. Mickel H.R. Olpe GABAB receptor antagonists: From synthesis to therapeutic applications Trends Pharmacol. Sci. 14 1993 391 394
6. C. Bon M. Galvan Electrophysiological actions of GABAB agonists and antagonists in rat dorso-lateral septal neurones in vitro Br. J. Pharmacol. 118 1996 961 967
7. G. Bonanno M. Raiteri Coexistence of carriers for dopamine and GABA uptake on a same nerve terminal in the rat brain Br. J. Pharmacol. 91 1987 237 243
8. N.G. Bowery GABAB receptor pharmacology Annu. Rev. Pharmacol. Toxicol. 33 1993 109 147
9. N.G. Bowery A.L. Hudson G.W. Price GABAA and GABAB receptor site distribution in the rat central nervous system Neuroscience 20 1987 365 383
10. F. Calon M. Goulet P.J. Blanchet J.C. Martel M.F. Piercey P.J. Bedard T. Di Paolo Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: Correlation with changes in dopamine and GABAA receptors in the striatopallidal complex Brain Res. 680 1995 43 52
11. A/benzodiazepine receptor complex and GABA content Neurochem. Int. 35 1999 81 91
12. D.C. Chu R.L. Albin A.B. Young J.B. Penney Distribution and kinetics of GABAB binding sites in rat central nervous system: a quantitative autoradiographic study Neuroscience 34 1990 341 357
13. D.C. Chu J.B. Penney Jr. A.B. Young Quantitative autoradiography of hippocampal GABAB and GABAA receptor changes in Alzheimer's disease Neurosci. Lett. 82 1987 246 252
14. M.R. DeLong Primate models of movement disorders of basal ganglia origin Trends Neurosci. 13 1990 281 285
15. S. Erhardt H. Nissbrandt G. Engberg Activation of nigral dopamine neurons by the selective GABA(B)-receptor antagonist SCH 50911 J. Neural Transm. 106 1999 383 394
16. W. Froestl S.J. Mickel G. von Sprecher P.J. Diel R.G. Hall L. Maier D. Strub V. Melillo P.A. Baumann R. Bernasconi C. Gentsch K. Hauser J. Jaekel G. Karlsson K. Klebs L. Maı̂re C. Marescaux M.F. Pozza M. Schmutz M.W. Steinmann H. van Riezen A. Vassout C. Mondadori H-R. Olpe P.C. Waldmeier H. Bittiger Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists J. Med. Chem. 38 1995 3313 3331
17. 3H](−)-baclofen Neurosci. Lett. 56 1985 183 188
18. C.R. Gerfen The neostriatal mosaic: Multiple levels of compartmental organization J. Neural Transm. Suppl. 36 1992 43 59
19. 3H]flunitrazepam Neuroscience 57 1993 673 681
20. B. Gomez-Mancilla R. Boucher C. Gagnon T. Di Paolo R. Markstein P.J. Bedard Effect of adding the D1 agonist CY 208–243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors Mov. Disord. 8 1993 144 150
21. M.R.Grondin Goulet P.J. Blanchet P.J. Bedard T. Di Paolo Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys Brain Res. 719 1996 129 137
22. M. Goulet M. Morissette R. Grondin P. Falardeau W. Rostène P.J. Bedard T. Di Paolo Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys Synapse 32 1999 153 164
23. P Greene Baclofen in the treatment of dystonia Clin. Neuropharmacol. 15 1992 276 288
24. R. Grondin M. Goulet T. Di Paolo P.J. Bedard Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates Brain Res. 735 1996 298 306
25. J.C. Hedreen M.R. DeLong Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque J. Comp. Neurol. 304 1991 569 595
26. M. Herkenham C.B. Pert Light microscopic localization of brain opiate receptors: A general autoradiographic method which preserves tissue quality J. Neurosci. 2 1982 1129 1149
27. O Hornykiewicz The neurochemical basis of the pharmacology of Parkinson's disease D.B. Calne Handbook of Experimental Pharmacology 1989 Springer-Verlag New York 185 204
28. S. Isomoto M. Kaibara Y. Sakurai-Yamashita Y. Nagayama Y. Uezono K. Yano K. Taniyama Cloning and tissue distribution of novel splice variants of the rat GABAB receptor Biochem. Biophys. Res. Commun. 253 1998 10 15
29. K.A. Jones B. Borowsky J.A. Tamm D.A. Craig M.M. Durkin M. Dai W.J. Yao M. Johnson C. Gunwaldsen L.Y. Huang C. Tang Q. Shen J.A. Salon K. Morse T. Laz K.E. Smith D. Nagarathnam S.A. Noble T.A. Branchek C. Gerald GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2 Nature 396 1998 674 679
30. K. Kaupmann K. Huggel J. Heid P.J. Flor S. Bischoff S.J. Mickel G. McMaster C. Angst H. Bittiger W. Froestl B. Bettler Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors Nature 386 1997 239 246
31. K. Kaupmann B. Malitschek V. Schuler J. Heid W. Froestl P. Beck J. Mosbacher S. Bischoff A. Kulik R. Shigemoto A. Karschin B. Bettler GABA(B)-receptor subtypes assemble into functional heteromeric complexes Nature 396 1998 683 687
32. K. Kaupmann V. Schuler J. Mosbacher S. Bischoff H. Bittiger J. Heid W. Froestl S. Leonhard T. Pfaff A. Karschin B. Bettler Human gamma-aminobutyric acid type B receptors are differentially expressed and regulate inwardly rectifying K+ channels Proc. Natl. Acad. Sci. USA 95 1998 14991 14996
33. Kuner R.G. Kohr S. Grunewald G. Eisenhardt A. Bach H.C. Kornau Role of heteromer formation in GABAB receptor function Science 283 1999 74 77
34. A.J. Lees K.M. Shaw G.M. Stern Baclofen in Parkinson's disease J. Neurol. Neurosurg. Psychiatry 41 1978 707 708
35. 3H]GABA binding in the human brain: Alterations in Parkinson's disease Brain Res. 127 1977 269 278
36. B. Malitschek D. Ruegg J. Heid K. Kaupmann H. Bittiger W. Frostl B. Bettler R. Kuhn Developmental changes of agonist affinity at GABABR1 receptor variants in rat brain Mol. Cell. Neurosci. 12 1998 56 64
37. M. Margeta-Mitrovic I. Mitrovic R.C. Riley L.Y. Jan A.I. Basbaum Immunohistochemical localization of GABA(B) receptors in the rat central nervous system J. Comp. Neurol. 405 1999 299 321
38. C.D. Marsden M.P. Sheehy GABA and movement disorders Adv. Biochem. Psychopharmacol. 30 1981 225 234
39. M. Matsumura L. Tremblay H. Richard M. Filion Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum Neuroscience 65 1995 59 70
40. B receptors make it to the top—As dimers Trends Pharmacol. Sci. 20 1999 87 89
41. D.D. Mott D.V. Lewis The pharmacology and function of central GABAB receptors Int. Rev. Neurobiol. 36 1994 97 223
42. A. Munoz M.M. Huntsman E.G. Jones GABA(B) receptor gene expression in monkey thalamus J. Comp. Neurol. 394 1998 118 126
43. P.A. Nausieda W.J. Weiner H.L. Klawans Dystonic foot response of Parkinsonism Arch. Neurol. 37 1980 132 136
44. G.Y.K. Ng J. Clark N. Coulombe N. Ethier T.E. Hebert R. Sullivan S. Kargman A. Chateauneuf N. Tsukamoto T. McDonald P. Whiting E. Mezey M.P. Johnson Q. Liu L.F. Kolakowski Jr. J.F. Evans T.I. Bonner G.P. O'Neill Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity J. Biol. Chem. 274 1999 7607 7610
45. J.G. Nutt Levodopa-induced dyskinesia: Review, observations, and speculations Neurology 40 1990 340 345
46. W.T. O'Connor Functional neuroanatomy of the basal ganglia as studied by dual-probe microdialysis Nucl. Med. Biol. 25 1998 743 746
47. C.W. Olanow W.C. Koller An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of Neurology Neurology 50 1998 S1 S57
48. H.R. Olpe H. Schellenberg W.P. Koella Rotational behavior induced in rats by intranigral application of GABA-related drugs and GABA antagonists Eur. J. Pharmacol. 45 1977 291 294
49. H.S. Pan J.B. Penney A.B. Young Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle J. Neurochem. 45 1985 1396 1404
50. A. Parent P.Y. Cote B. Lavoie Chemical anatomy of primate basal ganglia Prog. Neurobiol. 46 1995 131 197
51. A. Parent L.N. Hazrati Functional anatomy of the basal ganglia. I. The cortico–basal ganglia–thalamo–cortical loop Brain Res. Brain Res. Rev. 20 1995 91 127
52. G.S. Robertson S.R. Vincent H.C. Fibiger D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons Neuroscience 49 1992 285 296
53. 3H]flunitrazepam autoradiography Brain Res. 531 1990 95 104
54. M. Santiago A. Machado J. Cano In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: Differential modulation by baclofen Br. J. Pharmacol. 109 1993 814 818
55. J. Szabo W.M. Cowan A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis) J. Comp. Neurol. 222 1984 265 300
56. 14C]-2-deoxyglucose autoradiography Prog. Neuropsychopharmacol. Biol. Psychiatry 19 1995 795 810
57. P.C. Waldmeier K. Stocklin J.J. Feldtrauer Systemic administration of baclofen and the GABAB antagonist, CGP 35348, does not affect GABA, glutamate or aspartate in microdialysates of the striatum of conscious rats Naunyn Schmiedebergs Arch. Pharmacol. 345 1992 548 552
58. B.H. Westerink P. de Boer M. Santiago J.B. De Vries Do nerve terminals and cell bodies of nigrostriatal dopaminergic neurons of the rat contain similar receptors? Neurosci. Lett. 167 1994 109 112